Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

218.63 +0.51 (+0.23%)
Streaming Delayed Price Updated: 11:10 AM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Why Did LVLU Stock More Than Double Today? ↗
Activist investor Friedland Enterprises acquired approximately 5% of Lulu's Fashion Lounge’s common stock and also called for governance reforms in the company. 
Via Stocktwits
News headline image
INBS Stock Has Surged Over 330% So Far In January – But Retail Traders Are Warning Of A Pullback ↗
INBS shares were up more than 35% in premarket trading on Monday and were among the top trending tickers on Stocktwits. 
Via Stocktwits
Nuvve Stock In Focus As It Soars Over 78% — What Are Retail Investors Saying? ↗
Via Stocktwits
News headline image
SIDU Stock Is Already Up 390% In The Last Month – Why Is Retail Still Bullish? ↗
Sidus Space is enjoying its moment in the spotlight after winning a massive defense contract, and the growth witnessed by the space sector in recent months. 
Via Stocktwits
Topics Artificial Intelligence Government
What’s Behind Jet.AI Stock’s Rally Today? ↗
Via Stocktwits
News headline image
What’s Behind Hyperscale Data’s Surge Today? ↗
Hyperscale shares jump premarket as its bitcoin treasury exceeds its market cap at 117.8% 
Via Stocktwits
Why Are EVTV Shares Climbing Nearly 10% Today? ↗
Via Stocktwits
ISPO Jumps 46% On Take-Private Deal Just Four Years After Its IPO ↗
Via Stocktwits
CoreWeave’s Post-IPO Surge Fades: Investors’ AI Fears Leave Stock In A Tight Spot ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
What’s Driving Nutriband Shares Higher Today? ↗
Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million. 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Sidus Space Stock Is Up 218% This Month — Why Are Retail Investors Still Bullish? ↗
Sidus Space shares are rallying after the company gained a major defense contract and announced a public offering of 19 million shares this month. 
Via Stocktwits
Topics Government
News headline image
Why Reddit Is Needham’s ‘Top Pick’ For 2026 After A 40% Surge ↗
Analysts cite Reddit’s 100% human-created content and fast-growing ad platform as key drivers of future revenue. 
Via Stocktwits
Topics Artificial Intelligence Earnings Initial Public Offering
News headline image
DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence ↗
The company said that Halneuron demonstrated separation from placebo treated patients in terms of pain improvement but did not detail the scale of the said improvement. 
Via Stocktwits
CLSD Stock Plummets After Company Files For Bankruptcy Protection ↗
Via Stocktwits
Topics Bankruptcy
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition ↗
Via Stocktwits
Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments ↗
Via Stocktwits
Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study ↗
Via Stocktwits
News headline image
Why Did Dragonfly Energy Shares Plunge 44% Today? ↗
Dragonfly Energy announced a 1-for-10 reverse stock split on Tuesday. 
Via Stocktwits
News headline image
Why Did Aethlon Medical Stock Tumble Over 12% Today? ↗
Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 
Via Stocktwits
News headline image
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. ↗
The name change follows the company’s acquisition of GRID AI Corp in October. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did KTTA Stock Soar A Whopping 48% Today? ↗
The company announced the pricing of a public offering of 80 million shares of its common stock and said that the offering will extend its cash runway through at least the first half of 2028. 
Via Stocktwits
News headline image
LNAI Stock Soars Pre-Market After Immune Cell Therapy Gains Licensee Interest ↗
The cell therapy, Dendritic Cell Combination Therapy (DCCT), achieved complete regression of both primary and metastatic pancreatic tumors with no recurrence in humanized preclinical models. 
Via Stocktwits
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation ↗
Via Stocktwits
News headline image
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction ↗
The transaction is expected to close in early 2026, provided it receives all required approvals. 
Via Stocktwits
News headline image
Annovis Stock Rises After Company Confirms Meeting With Regulators To Discuss Drug In Treating Parkinson's Disease Dementia ↗
The meeting with the FDA is scheduled for January 2026. 
Via Stocktwits
Serina Therapeutics Stock Slumps Pre-Market After FDA Places Hold On Application To Initiate Clinical Trials For Experimental Therapy ↗
Via Stocktwits
News headline image
Why Is Retail Going Gaga Over INTS Stocks Today? ↗
The firm announced positive data from a study of INT230-6 in the treatment of metastatic and refractory cancers, with 15 of 64 patients in the trial surviving for more than 21 months. 
Via Stocktwits
News headline image
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options ↗
The company is exploring a range of strategic alternatives that may include, among other options, a sale of assets, Sensei said. 
Via Stocktwits
Topics Workforce
News headline image
ERNA Stock Rallies On Collaboration With Contract Manufacturer To Advance Lead Cell Therapy Into Clinical Trials ↗
The partnership will focus on activities to advance Ernexa’s lead cell therapy called ERNA-101 for the treatment of ovarian cancer into clinical manufacturing and trials. 
Via Stocktwits
News headline image
Intelligent Bio Solutions Stock Rises On New Contract For Drug Testing Technology ↗
The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said. 
Via Stocktwits
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.